✦ LIBER ✦

883 - Relationship of p53, uPA, pS2, EGF-R, and c-ERBB2, with response to systemic treatment in recurrent breast cancer patient

✍ Scribed by J.G.M. Klijn; E.M.J.J. Bems; M.P. Look; M.E. Meijer-van Gelder; J.A. Foekens

Book ID: 117665127
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 264 KB
Volume: 33
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(97)85576-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PP-9-5 Expression of uPA, c-erbB2, EGF-R

PP-9-5 Expression of uPA, c-erbB2, EGF-R and p53 in 488 primary breast cancer

✍ F. Spyratos; K. Hacène; V.Le Doussal; L. Durcos; M. Ferrero-Poüs; C. Bouchet; J. 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Assessment of response of bone metastase

Assessment of response of bone metastases to systemic treatment in patients with breast cancer

✍ R. C. Coombes; P. Dady; C. Parsons; V. R. McCready; H. T. Ford; J.- C. Gazet; T. 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 476 KB 👁 2 views

Apoptotic response to camptothecin and 7

Apoptotic response to camptothecin and 7-hydroxystaurosporine (UCN-01) in the 8 human breast cancer cell lines of the NCI anticancer drug screen: Multifactorial relationships with topoisomerase i, protein kinase C, Bcl-2, p53, MDM-2 and caspase pathways

✍ Wilberto Nieves-Neira; Yves Pommier 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 263 KB 👁 2 views

Derivatives of camptothecins, topoisomerase I inhibitors and 7-hydroxystaurosporine (UCN-01), a protein kinase C (PKC) inhibitor and cell cycle checkpoint abrogator, are promising anticancer drugs. We characterized the apoptotic response to camptothecin and UCN-01 for the 8 human breast carcinoma ce